FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagenavify.fhir.r5.rdc
Resource TypeDiagnosticReport
Idrdc-DiagnosticReport-agp-report.json
FHIR VersionR5

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

No narrative content found in resource


Source1

{
  "resourceType": "DiagnosticReport",
  "id": "rdc-DiagnosticReport-agp-report",
  "meta": {
    "profile": [
      "https://roche.com/fhir/iop/StructureDefinition/rdc-DiagnosticReport"
    ]
  },
  "status": "final",
  "code": {
    "coding": [
      {
        "code": "R7786-7",
        "system": "https://roche.com/fhir/CodeSystem/general",
        "display": "CGM Ambulatory Glucose Profile (AGP) During Reporting Period"
      }
    ]
  },
  "contained": [
    {
      "resourceType": "Observation",
      "id": "Obs-1",
      "meta": {
        "profile": [
          "https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-CGM"
        ]
      },
      "status": "final",
      "code": {
        "coding": [
          {
            "code": "434910001",
            "system": "http://snomed.info/sct",
            "display": "Interstitial fluid glucose concentration (observable entity)"
          }
        ]
      },
      "subject": {
        "reference": "Patient/34605fdc-74aa-4587-a5f0-92e6c5f64527"
      },
      "effectivePeriod": {
        "start": "2020-10-14T02:01:00+01:00",
        "end": "2020-10-14T02:06:00+01:00"
      },
      "valueSampledData": {
        "origin": {
          "value": 0,
          "code": "mg/dL",
          "system": "http://unitsofmeasure.org",
          "unit": "mg/dL"
        },
        "interval": 60000,
        "intervalUnit": "ms",
        "dimensions": 1,
        "data": "100 99 89 89",
        "extension": [
          {
            "url": "https://roche.com/fhir/iop/StructureDefinition/ext-CGMFlags",
            "valueString": "HI; X; X; LO"
          }
        ]
      },
      "extension": [
        {
          "url": "https://roche.com/fhir/iop/StructureDefinition/ext-CalibrationStatus",
          "valueString": "calibrated"
        }
      ],
      "device": {
        "reference": "Device/6ae8bff3-910a-419d-96f6-de0e8fd1d64d"
      }
    },
    {
      "resourceType": "Observation",
      "id": "Obs-2",
      "meta": {
        "profile": [
          "https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-CGM"
        ]
      },
      "status": "final",
      "code": {
        "coding": [
          {
            "code": "434910001",
            "system": "http://snomed.info/sct",
            "display": "Interstitial fluid glucose concentration (observable entity)"
          }
        ]
      },
      "subject": {
        "reference": "Patient/34605fdc-74aa-4587-a5f0-92e6c5f64527"
      },
      "effectivePeriod": {
        "start": "2020-10-15T02:01:00+01:00",
        "end": "2020-10-15T02:06:00+01:00"
      },
      "valueSampledData": {
        "origin": {
          "value": 0,
          "code": "mg/dL",
          "system": "http://unitsofmeasure.org",
          "unit": "mg/dL"
        },
        "interval": 60000,
        "intervalUnit": "ms",
        "dimensions": 1,
        "data": "100 99 89 89",
        "extension": [
          {
            "url": "https://roche.com/fhir/iop/StructureDefinition/ext-CGMFlags",
            "valueString": "HI; X; X; LO"
          }
        ]
      },
      "extension": [
        {
          "url": "https://roche.com/fhir/iop/StructureDefinition/ext-CalibrationStatus",
          "valueString": "calibrated"
        }
      ],
      "device": {
        "reference": "Device/6ae8bff3-910a-419d-96f6-de0e8fd1d64d"
      }
    },
    {
      "resourceType": "Observation",
      "id": "Obs-3",
      "meta": {
        "profile": [
          "https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
        ]
      },
      "status": "final",
      "code": {
        "coding": [
          {
            "code": "97507-8",
            "system": "http://loinc.org",
            "display": "Average glucose [Mass/ volume] in Interstitial fluid during Reporting Period"
          }
        ]
      },
      "effectivePeriod": {
        "start": "2020-10-15T02:01:00+01:00",
        "end": "2020-10-15T02:06:00+01:00"
      },
      "valueQuantity": {
        "system": "http://unitsofmeasure.org",
        "code": "mg/dL",
        "unit": "mg/dL",
        "value": 136
      }
    },
    {
      "resourceType": "Observation",
      "id": "Obs-4",
      "meta": {
        "profile": [
          "https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
        ]
      },
      "status": "final",
      "code": {
        "coding": [
          {
            "code": "R9599-2",
            "system": "https://roche.com/fhir/CodeSystem/general",
            "display": "CGM Glycemic Variability (%GV), during reporting period"
          }
        ]
      },
      "effectivePeriod": {
        "start": "2020-10-15T02:01:00+01:00",
        "end": "2020-10-15T02:06:00+01:00"
      },
      "valueQuantity": {
        "system": "http://unitsofmeasure.org",
        "code": "mg/dL",
        "unit": "mg/dL",
        "value": 35.5
      }
    },
    {
      "resourceType": "Observation",
      "id": "Obs-5",
      "meta": {
        "profile": [
          "https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
        ]
      },
      "status": "final",
      "code": {
        "coding": [
          {
            "code": "97504-5",
            "system": "http://loinc.org",
            "display": "Percent sensor usage"
          }
        ]
      },
      "effectivePeriod": {
        "start": "2020-10-15T02:01:00+01:00",
        "end": "2020-10-15T02:06:00+01:00"
      },
      "valueQuantity": {
        "system": "http://unitsofmeasure.org",
        "code": "%",
        "unit": "%",
        "value": 100
      }
    },
    {
      "resourceType": "Observation",
      "id": "Obs-6",
      "meta": {
        "profile": [
          "https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
        ]
      },
      "status": "final",
      "code": {
        "coding": [
          {
            "code": "97506-0",
            "system": "http://loinc.org",
            "display": "Glucose management indicator"
          }
        ]
      },
      "effectivePeriod": {
        "start": "2020-10-15T02:01:00+01:00",
        "end": "2020-10-15T02:06:00+01:00"
      },
      "valueQuantity": {
        "system": "http://unitsofmeasure.org",
        "code": "%",
        "unit": "%",
        "value": 6.6
      }
    },
    {
      "resourceType": "Observation",
      "id": "Obs-7",
      "meta": {
        "profile": [
          "https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
        ]
      },
      "status": "final",
      "code": {
        "coding": [
          {
            "code": "104639-0",
            "system": "http://loinc.org",
            "display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, very high (TAR-VH >250 mg/dL (>13.9 mmol/L) (hyperglycemic) during reporting period"
          }
        ]
      },
      "effectivePeriod": {
        "start": "2020-10-15T02:01:00+01:00",
        "end": "2020-10-15T02:06:00+01:00"
      },
      "valueQuantity": {
        "system": "http://unitsofmeasure.org",
        "code": "%",
        "unit": "%",
        "value": 3
      }
    },
    {
      "resourceType": "Observation",
      "id": "Obs-8",
      "meta": {
        "profile": [
          "https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
        ]
      },
      "status": "final",
      "code": {
        "coding": [
          {
            "code": "104640-8",
            "system": "http://loinc.org",
            "display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, high (TAR-H) 181-250 mg/ dL (10.1-13.9 mmol/L) (hyperglycemic) during reporting period"
          }
        ]
      },
      "effectivePeriod": {
        "start": "2020-10-15T02:01:00+01:00",
        "end": "2020-10-15T02:06:00+01:00"
      },
      "valueQuantity": {
        "system": "http://unitsofmeasure.org",
        "code": "%",
        "unit": "%",
        "value": 14
      }
    },
    {
      "resourceType": "Observation",
      "id": "Obs-9",
      "meta": {
        "profile": [
          "https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
        ]
      },
      "status": "final",
      "code": {
        "coding": [
          {
            "code": "97510-2",
            "system": "http://loinc.org",
            "display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent in target glucose range (70-180 mg/dL [3.9-10.0 mmol/L]) during reporting period. The primary goal for effective and safe glucose control is to increase the TIR whil"
          }
        ]
      },
      "effectivePeriod": {
        "start": "2020-10-15T02:01:00+01:00",
        "end": "2020-10-15T02:06:00+01:00"
      },
      "valueQuantity": {
        "system": "http://unitsofmeasure.org",
        "code": "%",
        "unit": "%",
        "value": 78
      }
    },
    {
      "resourceType": "Observation",
      "id": "Obs-10",
      "meta": {
        "profile": [
          "https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
        ]
      },
      "status": "final",
      "code": {
        "coding": [
          {
            "code": "104641-6",
            "system": "http://loinc.org",
            "display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, low (TBR-L) 54-69 mg/dL (3.0-3.8 mmol/L) (hypoglycemic) during reporting period"
          }
        ]
      },
      "effectivePeriod": {
        "start": "2020-10-15T02:01:00+01:00",
        "end": "2020-10-15T02:06:00+01:00"
      },
      "valueQuantity": {
        "system": "http://unitsofmeasure.org",
        "code": "%",
        "unit": "%",
        "value": 5
      }
    },
    {
      "resourceType": "Observation",
      "id": "Obs-11",
      "meta": {
        "profile": [
          "https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report"
        ]
      },
      "status": "final",
      "code": {
        "coding": [
          {
            "code": "104642-4",
            "system": "http://loinc.org",
            "display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, very low (TBR-VL) <54 mg/dL (<3.0 mmol/L) (hypoglycemic) during reporting period"
          }
        ]
      },
      "effectivePeriod": {
        "start": "2020-10-15T02:01:00+01:00",
        "end": "2020-10-15T02:06:00+01:00"
      },
      "valueQuantity": {
        "system": "http://unitsofmeasure.org",
        "code": "%",
        "unit": "%",
        "value": 0
      }
    }
  ],
  "subject": {
    "reference": "Patient-Reference"
  },
  "effectivePeriod": {
    "start": "2023-10-03T06:32:00+01:00",
    "end": "2023-10-03T07:30:00+01:00"
  },
  "performer": [
    {
      "reference": "Organization-Reference"
    },
    {
      "reference": "Practitioner-Reference"
    }
  ],
  "result": [
    {
      "reference": "#Obs-1"
    },
    {
      "reference": "#Obs-2"
    },
    {
      "reference": "#Obs-3"
    },
    {
      "reference": "#Obs-4"
    },
    {
      "reference": "#Obs-5"
    },
    {
      "reference": "#Obs-6"
    },
    {
      "reference": "#Obs-7"
    },
    {
      "reference": "#Obs-8"
    },
    {
      "reference": "#Obs-9"
    },
    {
      "reference": "#Obs-10"
    },
    {
      "reference": "#Obs-11"
    }
  ],
  "presentedForm": [
    {
      "url": "https://aws-cloud-location-of-AGP-Report",
      "data": "QUdQIHJlcG9ydA==",
      "hash": "2c9fa2fc8f4fd1b3184821e27dfc0b6960724633",
      "contentType": "application/pdf",
      "creation": "2023-10-03T07:30:00+01:00",
      "title": "AGP-Report"
    }
  ]
}